The Food and Drug Administration has granted Fast Track designation to emrusolmin (TEV-56286) for the treatment of multiple system atrophy.

Final participant randomized to complete enrollment in Phase 1 clinical trial assessing safety of investigational gene ...

In this article, we will be taking a look at the 12 Cheap Healthcare Stocks to Buy Now. Teva Pharmaceutical Industries ...

Research Triangle Park, North Carolina Friday, September 19, 2025, 10:00 Hrs [IST] ...

Dozens of Jeeps, Land Rovers, a Pinzgauer and other vehicles used for off-roading lined up outside a Walmart in Holly Springs ...

A poster, entitled, “ATH434 Slowed Disease Progression in a Phase 2 Study in Multiple System Atrophy,” was presented by Daniel Claassen, M.D., M.S., Professor of Neurology at Vanderbilt University ...

A leading neurologist involved in development of Alterity's lead compound ATH434 believes it could be a game changer for sufferers of MSA.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) added that the U.S. FDA granted Orphan Drug designation to emrusolmin for ...

Biogen Inc. (NASDAQ: BIIB) is one of the best drug stocks to buy right now. In a report released on September 12, Sumant ...

AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced the completion of enrollment for REGENERATE MSA-101, its Phase 1 ...

In recent years, the U.S. Food and Drug Administration (FDA) has approved a wave of new therapies, including gene therapies, ...

More than 40 people gathered at the Bear Valley Springs Equestrian Center Saturday to honor the memory of Sara Nilson, who died in 2023, and to raise awareness about the ...